Childhood outcomes of neonates diagnosed with portal vein thrombosis

Iris Morag1, Prakesh S Shah, Monica Epelman

  • 1Neonatology, Mayanei Hayeshua Medical Center, Bnei Brak, Israel. irismorag@gmail.com

Insights

Neonatal portal vein thrombosis (PVT) can lead to long-term childhood outcomes like asymptomatic left lobar atrophy (LLA) and progressive splenomegaly. Long-term ultrasonographic follow-up is crucial for monitoring these outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Neonatal Medicine
  • Hepatology

Background:

  • Neonatal portal vein thrombosis (PVT) is a serious condition with potential long-term consequences.
  • Understanding the childhood outcomes of neonatal PVT is essential for appropriate management and follow-up.

Purpose of the Study:

  • To determine the long-term childhood outcomes of neonates diagnosed with portal vein thrombosis (PVT).

Main Methods:

  • A retrospective chart review was conducted on neonates diagnosed with PVT.
  • Follow-up data included physical examinations, laboratory tests, and ultrasonographic examinations up to age 2 years and beyond.

Main Results:

  • Of 70 children followed, 28% had asymptomatic left lobar atrophy (LLA), 7% developed progressive splenomegaly, and 3% required shunting for portal hypertension.
  • Ultrasonographic follow-up was the most sensitive method for detecting progression.
  • Liver function tests showed mild abnormalities in some children, and thrombophilia was detected in a subset of patients.

Conclusions:

  • Neonatal PVT can result in persistent asymptomatic LLA, slowly progressive splenomegaly, and portal hypertension requiring intervention in childhood.
  • Periodic, long-term ultrasonographic follow-up is recommended for neonates diagnosed with PVT to monitor for disease progression.
Abstract

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...